Elevated microRNA-214-3p level ameliorates neuroinflammation after spinal cord ischemia–reperfusion injury by inhibiting Nmb/Cav3.2 pathway
International Immunopharmacology · 2024-05 · 133 · 112031
DOI: 10.1016/j.intimp.2024.112031 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-05. Verfasst von Guo-Qiang Xia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China. Hauptthemen laut MEDLINE: Calcium Channels, T-Type, MicroRNAs, Neuroinflammatory Diseases, Reperfusion Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Neuromedin B (Nmb) plays a pivotal role in the transmission of neuroinflammation, particularly during spinal cord ischemia-reperfusion injury (SCII). However, the detailed molecular mechanisms underlying this process remain elusive. METHODS: The SCII model was established by clamping the abdominal aorta of male Sprague-Dawley (SD) rats for 60 min. The protein expression levels of Nmb, Cav3.2, and IL-1β were detected by Western blotting, while miR-214-3p expression was quantified by qRT-PCR. The targeted regulation between miR-214-3p and Nmb was investigated using a dual-luciferase reporter gene assay. The cellular localization of Nmb and Cav3.2 with cell-specific markers was visualized by immunofluorescence staining. The specific roles of miR-214-3p on the Nmb/Cav3.2 interactions in SCII-injured rats were explored by intrathecal injection of Cav3.2-siRNA, PD168368 (a specific NmbR inhibitor) and synthetic miR-214-3p agomir and antagomir in separate experiments. Additionally, hind-limb motor function was evaluated using the modified Tarlov scores. RESULTS: Compared to the Sham group, the protein expression levels of Nmb, Cav3.2, and the proinflammatory factor Interleukin(IL)-1β were significantly elevated at 24 h post-SCII. Intrathecal injection of PD168368 and Cav3.2-siRNA significantly suppressed the expression of Cav3.2 and IL-1β compared to the SCII group. The miRDB database and dual-luciferase reporter gene assay identified Nmb as a direct target of miR-214-3p. As expected, in vivo overexpression of miR-214-3p by agomir-214-3p pretreatment significantly inhibited the increases in Nmb, Cav3.2 and IL-1β expression and improved lower limb motor function in SCII-injured rats, while antagomiR-214-3p pretreatment reversed these effects. CONCLUSIONS: Nmb protein levels positively correlated with Cav3.2 expression in SCII rats. Upregulating miR-214-3p ameliorated hind-limb motor function and protected against neuroinflammation via inhibiting the aberrant Nmb/Cav3.2 interactions and downstream IL-1β release. These findings provide novel therapeutic targets for clinical prevention and treatment of SCII.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.
- Department of Pain Medicine, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China.
- Department of Anesthesiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China. Electronic address: zhangzaili333@sina.com.
- Department of Anesthesiology, The First Hospital of China Medical University, Shenyang 110001, Liaoning, China. Electronic address: shirley037305@hotmail.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xia, G. Q., Xu, M., Sun, C., Zhang, Z. L., & Li, X. Q. (2024). Elevated microRNA-214-3p level ameliorates neuroinflammation after spinal cord ischemia–reperfusion injury by inhibiting Nmb/Cav3.2 pathway. International Immunopharmacology, 133, 112031. https://doi.org/10.1016/j.intimp.2024.112031
Vancouver
Xia GQ, Xu M, Sun C, Zhang ZL, Li XQ. Elevated microRNA-214-3p level ameliorates neuroinflammation after spinal cord ischemia–reperfusion injury by inhibiting Nmb/Cav3.2 pathway. International Immunopharmacology. 2024;133:112031. doi:10.1016/j.intimp.2024.112031
BibTeX
@article{Xia2024,
author = {Xia, Guo-Qiang and Xu, Miao and Sun, Cong and Zhang, Zai-Li and Li, Xiao-Qian},
title = {Elevated microRNA-214-3p level ameliorates neuroinflammation after spinal cord ischemia–reperfusion injury by inhibiting Nmb/Cav3.2 pathway},
journal = {International Immunopharmacology},
year = {2024},
volume = {133},
pages = {112031},
doi = {10.1016/j.intimp.2024.112031}
}
EUVIMED